These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

523 related articles for article (PubMed ID: 34694167)

  • 1. Knowledge, attitude, practice and barriers towards pharmacovigilance and adverse drug reactions reporting among healthcare professionals in Turkey: a systematic review.
    Khan Z; Karatas Y; Martins MAP; Jamshed S; Rahman H
    Curr Med Res Opin; 2022 Jan; 38(1):145-154. PubMed ID: 34694167
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Knowledge, attitudes and practice regarding pharmacovigilance and adverse drug reaction reporting among physicians and pharmacists in Egypt: a step toward personalized medicine implementation.
    Aziz AA; Rogers S; Hassanien O; Shalaby L; Nagy M
    Per Med; 2022 Nov; 19(6):495-507. PubMed ID: 36239598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploring the factors and barriers of healthcare professionals in tertiary care hospitals toward pharmacovigilance: a multicenter study from Khyber Pakhtunkhwa, Pakistan.
    Sharif MJH; Farrukh MJ; Khan FU; Khan Q; Ahmed SS; Kousar R; Ahmad T; Abid SMA; Ashfaq M; Khan SA
    Curr Med Res Opin; 2022 Apr; 38(4):595-605. PubMed ID: 35166143
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacovigilance education to healthcare professionals: Will it affect their performance in reporting adverse drug reactions?
    Ibrahim DM; Shawki MA; Solayman MH; Sabri NA
    Int J Clin Pract; 2021 Nov; 75(11):e14731. PubMed ID: 34387008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of patient reporting of adverse drug reactions to the UK 'Yellow Card Scheme': literature review, descriptive and qualitative analyses, and questionnaire surveys.
    Avery AJ; Anderson C; Bond CM; Fortnum H; Gifford A; Hannaford PC; Hazell L; Krska J; Lee AJ; McLernon DJ; Murphy E; Shakir S; Watson MC
    Health Technol Assess; 2011 May; 15(20):1-234, iii-iv. PubMed ID: 21545758
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Knowledge, attitude and practice of Malaysian healthcare professionals toward adverse drug reaction reporting: a systematic review.
    Balan S
    Int J Pharm Pract; 2021 Aug; 29(4):308-320. PubMed ID: 34289016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exploring healthcare professionals' knowledge, attitude, and practices towards pharmacovigilance: a cross-sectional survey.
    Hussain R; Hassali MA; Hashmi F; Akram T
    J Pharm Policy Pract; 2021 Jan; 14(1):5. PubMed ID: 33397478
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Systematic Review of Healthcare Professionals' Knowledge, Attitudes, and Practices Regarding Adverse Drug Reaction Reporting in Ethiopia.
    Anbeo ZG; Abacıoğlu N
    Turk J Pharm Sci; 2023 Jul; 20(3):198-209. PubMed ID: 37417202
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Awareness, knowledge, attitude and practice of adverse drug reaction reporting among health workers and patients in selected primary healthcare centres in Ibadan, southwestern Nigeria.
    Adisa R; Omitogun TI
    BMC Health Serv Res; 2019 Dec; 19(1):926. PubMed ID: 31796034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Knowledge, Attitude, and Practices regarding Pharmacovigilance and Adverse Drug Reaction reporting among Dental Students in a Teaching Hospital, Jodhpur, India: A Cross-sectional Study.
    Chhabra KG; Sharma A; Chhabra C; Reddy JJ; Deolia SG; Mittal Y
    J Contemp Dent Pract; 2017 Oct; 18(10):964-969. PubMed ID: 28989138
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Knowledge, Attitude, and Barriers Toward ADRs Reporting Among Health-Care Professionals at Tertiary Care Health Settings in Peshawar, Pakistan: A Web Based Study.
    Ali I; Ahmad W; Ullah AR; Khan F; Ijaz M; Khan S; Khan TM
    Hosp Pharm; 2021 Aug; 56(4):384-391. PubMed ID: 34381279
    [No Abstract]   [Full Text] [Related]  

  • 12. Barriers and facilitators to pharmacovigilance activities in Pakistan: A healthcare professionals-based survey.
    Hussain R; Akram T; Hassali MA; Muneswarao J; Rehman AU; Hashmi F; Babar ZU
    PLoS One; 2022; 17(7):e0271587. PubMed ID: 35905133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Knowledge, attitudes and perspective on adverse drug reaction reporting in a public sector hospital in South Africa: baseline analysis.
    Terblanche A; Meyer JC; Godman B; Summers RS
    Hosp Pract (1995); 2017 Dec; 45(5):238-245. PubMed ID: 28914115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patient versus healthcare professional spontaneous adverse drug reaction reporting: a systematic review.
    Inch J; Watson MC; Anakwe-Umeh S
    Drug Saf; 2012 Oct; 35(10):807-18. PubMed ID: 22928729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Knowledge and attitude of health-care professionals in hospitals towards pharmacovigilance in Saudi Arabia.
    Alshammari TM; Alamri KK; Ghawa YA; Alohali NF; Abualkol SA; Aljadhey HS
    Int J Clin Pharm; 2015 Dec; 37(6):1104-10. PubMed ID: 26216270
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Health Professionals' Knowledge, Attitudes and Practices about Pharmacovigilance in India: A Systematic Review and Meta-Analysis.
    Bhagavathula AS; Elnour AA; Jamshed SQ; Shehab A
    PLoS One; 2016; 11(3):e0152221. PubMed ID: 27010447
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors associated with spontaneous adverse drug reaction reporting among healthcare professionals in Vietnam.
    Le TT; Nguyen TTH; Nguyen C; Tran NH; Tran LA; Nguyen TB; Nguyen N; Nguyen HA
    J Clin Pharm Ther; 2020 Feb; 45(1):122-127. PubMed ID: 31486525
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An Awareness of Pharmacovigilance Among Healthcare Professionals Due to an Underreporting of Adverse Drug Reactions Issue: A Systematic Review of the Current State, Obstacles, and Strategy.
    Putri RA; Ikawati Z; Rahmawati F; Yasin NM
    Curr Drug Saf; 2024; 19(3):317-331. PubMed ID: 38989832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current Scenario and Future Prospects of Adverse Drug Reactions (ADRs) Monitoring and Reporting Mechanisms in the Rural Areas of India.
    Shukla S; Sharma P; Gupta P; Pandey S; Agrawal R; Rathour D; Kumar Kewat D; Singh R; Kumar Thakur S; Paliwal R; Sulakhiya K
    Curr Drug Saf; 2024; 19(2):172-190. PubMed ID: 37132145
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Awareness, knowledge, and attitude toward adverse drug reaction (ADR) reporting among healthcare professionals in Ghana.
    Yawson AA; Abekah-Nkrumah G; Okai GA; Ofori CG
    Ther Adv Drug Saf; 2022; 13():20420986221116468. PubMed ID: 35966898
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.